ABA. G. Beiske

A. G. Beiske

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. G. Beiske has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • E. Svensson

    Department of Adult Mental Health, Division of Mental Health, Norwegian Institute of Public Health, Oslo, Norway

    2 shared publications
  • B. Czujko

    Department of Psychiatry, Ullevål University Hospital, Oslo

    1 shared publication
  • E. D. Pedersen

    Department of Neurology, Akershus University Hospital, Nordbyhagen

    1 shared publication
  • H. Naess

    Department of Neurology, Haukeland University Hospital, Bergen, Norway

    1 shared publication
  • H.J. Hansen

    Department of Neurology, Aarhus Hospital, Aarhus University Hospital, Aarhus, Denmark

    1 shared publication
  • I. Elovaara

    Neuroimmunology Unit, Department of Neurology, Tampere University Hospital and Medical School, University of Tampere, Tampere, Finland

    1 shared publication

Latest Publications

  • Fatigue in Parkinson’s disease: a short update

    by A. G. Beiske, E. Svensson

    This article provides a short update on fatigue in Parkinson's disease (PD), focusing on measurements, prevalence, associated factors, pathophysiology and treatment. As long as there is no universally accepted definition of fatigue the definition used has to be stated. Different aspects of fatigue, namely physical-, mental- and chronic fatigue will be discussed. The many questionnaires used to assess fatigue measure different aspects of fatigue, making comparisons between studies difficult. Examples of uni- and multidimensional self-report questionnaires are given. In PD patients, the wide range of prevalence of fatigue (37-56%) is largely because of varying definitions of fatigue and populations tested. Without understanding the pathophysiology of subjective fatigue, the development of effective therapies is a challenge.


  • Health-related quality of life in secondary progressive multiple sclerosis

    by A.G. Beiske, H. Naess, J.H. Aarseth, O. Andersen, I. Elovaara, M. Farkkila, H.J. Hansen, S.I. Mellgren, M. Sandberg-Wollheim, P.S. Sorensen, et al.

    Common disability scales in multiple sclerosis (MS) are often weighted towards physical disability. Non-motor symptoms such as depression, fatigue and pain substantially influence wellbeing in MS. Health-related quality of life (HRQoL) measures the broader impact of MS and might indicate less obvious disease burdens. We analysed HRQoL, using the Nottingham Health Profile Part I (NHP-I), among 345 secondary progressive MS (SPMS) patients participating in a randomized trial of interferon-β1a (IFN-β1a), 22 μg subcutaneously weekly, or matching placebo. The results did not reveal any beneficial effect of IFN-β1a in any outcome measure. NHP-I sub- and sum scores were compared for 217 population controls and correlated with demographic and clinical disease variables. SPMS patients had lower NHP-I sum and all subscores than the controls. Patients experiencing disease progression reported worse NHP-I sum scores. Increased fatigue, Expanded Disability Status Scale (EDSS) and Arm Index scores were independently associated with reduction in several NHP-I subscores. SPMS patients had significantly lower HRQoL than controls and physical disability (EDSS and Arm Index), disease progression and fatigue strongly influenced this. MS


  • Pain and sensory complaints in multiple sclerosis

    by A. G. Beiske, E. D. Pedersen, B. Czujko, K.‐M. Myhr

    Pain is a frequent and disabling symptom among multiple sclerosis (MS) patients. The importance of this problem was investigated in a hospital based MS population.A total of 142 MS patients underwent neurological examination and a structured interview for registration of pain and sensory symptoms.One‐hundred and five patients reported sensory and/or pain symptoms. Pain was reported by 93 patients and was most frequently located in the limbs and lumbar region. The presence of pain was independent of gender, age at onset and examination, disability, disease course and duration. The most frequently reported characteristics of the symptoms were paresthesia, neuralgia and deep muscular aching. About 40% of the patients reported that the symptoms had important influence on daily activities. Only one‐third of the patients were treated for their pain.Pain is a frequent and disabling symptom, independent of demographic and clinical variables in MS patients. The low frequency of treatment for these symptoms indicates a need for improved attention to this problem.